JP2025509722A5 - - Google Patents

Info

Publication number
JP2025509722A5
JP2025509722A5 JP2024555092A JP2024555092A JP2025509722A5 JP 2025509722 A5 JP2025509722 A5 JP 2025509722A5 JP 2024555092 A JP2024555092 A JP 2024555092A JP 2024555092 A JP2024555092 A JP 2024555092A JP 2025509722 A5 JP2025509722 A5 JP 2025509722A5
Authority
JP
Japan
Prior art keywords
rasm
less
imac
preparation
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024555092A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025509722A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/064657 external-priority patent/WO2023178325A1/en
Publication of JP2025509722A publication Critical patent/JP2025509722A/ja
Publication of JP2025509722A5 publication Critical patent/JP2025509722A5/ja
Pending legal-status Critical Current

Links

JP2024555092A 2022-03-18 2023-03-17 医薬組換えヒト酸性スフィンゴミエリナーゼ組成物及び方法 Pending JP2025509722A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263321636P 2022-03-18 2022-03-18
US63/321,636 2022-03-18
PCT/US2023/064657 WO2023178325A1 (en) 2022-03-18 2023-03-17 Pharmaceutical recombinant human acid sphingomyelinase compositions and methods

Publications (2)

Publication Number Publication Date
JP2025509722A JP2025509722A (ja) 2025-04-11
JP2025509722A5 true JP2025509722A5 (https=) 2026-03-24

Family

ID=86051983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024555092A Pending JP2025509722A (ja) 2022-03-18 2023-03-17 医薬組換えヒト酸性スフィンゴミエリナーゼ組成物及び方法

Country Status (12)

Country Link
US (1) US20230365946A1 (https=)
EP (1) EP4493684A1 (https=)
JP (1) JP2025509722A (https=)
KR (1) KR20240156645A (https=)
CN (1) CN119365593A (https=)
AR (1) AR128825A1 (https=)
AU (1) AU2023235321A1 (https=)
CA (1) CA3254814A1 (https=)
IL (1) IL315655A (https=)
MX (1) MX2024011382A (https=)
TW (1) TW202403043A (https=)
WO (1) WO2023178325A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4594462A1 (en) 2022-09-28 2025-08-06 Genzyme Corporation Systems and devices for producing biological products and methods of using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215051A (en) 1979-08-29 1980-07-29 Standard Oil Company (Indiana) Formation, purification and recovery of phthalic anhydride
US5773278A (en) 1991-05-03 1998-06-30 Mount Sinai Medical Center Acid sphingomyelinase gene
US20020137173A1 (en) * 2001-02-05 2002-09-26 Dae-Kyong Kim Membrane-associated sphingomyelinase derived from bovine brain, isolation method therefor and anti-sphingomyelinase monoclonal anitibody
US7527956B2 (en) * 2003-06-12 2009-05-05 Genzyme Corporation Modified human acid sphingomyelinase having increased activity, and methods for making the same
WO2008085988A1 (en) 2007-01-05 2008-07-17 Amgen Inc. Methods of purifying proteins
KR20100103595A (ko) 2008-01-18 2010-09-27 에프. 호프만-라 로슈 아게 비-글라이코실화된 단백질의 정제
RU2012151132A (ru) 2010-05-19 2014-06-27 Ф. Хоффманн-Ля Рош Аг Хроматография с гиброфобным взаимодействием
AR082319A1 (es) * 2010-07-22 2012-11-28 Biomarin Pharm Inc Produccion de una n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforilada y sus usos
EP2997036B1 (en) 2013-05-15 2021-03-03 Medimmune Limited Purification of recombinantly produced polypeptides
DK3728287T3 (da) 2017-12-19 2024-06-10 CSL Behring Lengnau AG Proteinoprensning og virusinaktivering med alkylglycosider
PY1939780A (es) 2018-05-25 2019-12-04 Genzyme Corp Composiciones farmacéuticas para el tratamiento de la deficiencia de esfingomielinasa ácida

Similar Documents

Publication Publication Date Title
EP1568710B1 (en) Antibody purification method
JP3262128B2 (ja) 蛋白質の精製方法
KR930003665B1 (ko) 에리스로포이에틴의 정제방법
JP2022536486A5 (https=)
KR100847883B1 (ko) 인체 혈청알부민 다량체의 제거방법
WO2019184368A1 (zh) 一种高纯度rhNGF的制备方法
JP2025510977A5 (https=)
JP2025509722A5 (https=)
CN1250567C (zh) 钙离子结合蛋白的提纯方法
Davies et al. Purification of some tricarboxylic acid cycle enzymes from beef heart using affinity elution chromatography
CN112175063B (zh) 一种高效液相色谱法制备高纯度重组表皮生长因子的工艺
RU2024129669A (ru) Фармацевтические композиции на основе рекомбинантной кислой сфингомиелиназы человека и связанные способы
CN1120365C (zh) 一种新的亲和介质和用该介质纯化白蛋白的方法
WO1995004077A1 (en) Method of purifying plasminogen
JPS6160050B2 (https=)
KR20200022052A (ko) 설파타아제 단백질을 정제하는 방법
JP2003082422A (ja) ガリウムの回収方法
JP2002506882A (ja) 金属含有リボヌクレオチドポリペプチド
JP4154743B2 (ja) インターロイキン6レセプターの精製方法
JPH05170799A (ja) ヒトインターロイキン8の精製方法
CN118702802A (zh) 一种纯化重组人生长激素的方法
JPH11287792A (ja) インターロイキン6レセプターの精製法
JPS63145297A (ja) タンパク質の精製方法
CN113024655A (zh) 一种高效去除rhNGF前体的纯化方法
JPH01222782A (ja) コラゲナーゼインヒビターの精製法